Last reviewed · How we verify

NCT04776577

Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath

Completed NA Last updated 9 January 2024
What this trial tests

NA trial testing Wirecath@ and Abbott PressureWire® (20 patients) in Coronary Disease in 45 participants. Completed in 25 October 2021.

Timeline
25 February 2021
Primary endpoint
25 October 2021
25 October 2021

Quick facts

Lead sponsorVastra Gotaland Region
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment45
Start date25 February 2021
Primary completion25 October 2021
Estimated completion25 October 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

19 and older, any sex, with Coronary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In summary, the purpose of the study is to evaluate whether the Wirecath device can be used as a standard pressure wire in a safe and efficient way.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Safety and Feasibility Using a Fluid-Filled Wire to Avoid Hydrostatic Errors in Physiological Intracoronary Measurements.
    Råmunddal T, Dworeck C, Torild P, Andréen S, et al · · 2024 · PMID 38204600 · DOI 10.1155/2024/6664482

Verify or expand the search:

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

Other Vastra Gotaland Region trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing